金域医学：股东国创开元减持计划期限届满，未减持公司股份

Core Viewpoint - Kingmed Diagnostics (SH 603882, closing price: 29.02 yuan) announced on October 29 that the share reduction plan by Guochuang Kaiyuan, disclosed on July 9, 2025, has resulted in no shares being reduced during the plan period, which has now expired [1] Company Summary - For the fiscal year 2024, Kingmed Diagnostics reported that its revenue composition is as follows: third-party medical diagnostics accounted for 92.17%, while other businesses made up 7.83% [1] - As of the report date, Kingmed Diagnostics has a market capitalization of 13.4 billion yuan [1]